Mahon Paul A

EVP &General Counsel | EVP &General Counsel

1 company

Average

Trades Analyzed

12M Win Rate

16.4%

Avg 3M Return

-7.5%

Avg 12M Return

-27.3%

Mahon Paul A is an EVP &General Counsel at United Therapeutics Corporation. Recent SEC Form 4 filings include 0 buys and 75 sells.

Estimated insider holdings value: $20.4M based on current market prices.

Holdings by Company

UTHRMar 5, 2026

Current Shares36.8K

Value$20.38M

Net Activity-599,952

Bought: 0Sold: 600.0K

Showing 10 filings

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Mar 5, 2026	UTHR United Therapeutics Corporation	EVP &General Counsel	Sale+OE	8,300	$483.16	$4,010,187.14	-2.2%	+12.9%	-
Feb 19, 2026	UTHR United Therapeutics Corp	EVP &General Counsel	Sale+OE	8,300	$476.34	$3,953,588.22	-2.4%	+17.4%	-
Feb 5, 2026	UTHR United Therapeutics Corp	EVP &General Counsel	Sale+OE	8,300	$483.25	$4,010,939.67	-3.3%	+24.6%	-
Jan 15, 2026	UTHR United Therapeutics Corp	EVP &General Counsel	Sale+OE	8,300	$469.89	$3,900,121.92	-3.3%	+21.1%	-
Jan 2, 2026	UTHR United Therapeutics Corp	EVP &General Counsel	Sale+OE	8,300	$485.43	$4,029,076.32	-2.5%	+14.8%	-
Dec 24, 2025	UTHR United Therapeutics Corp	EVP &General Counsel	Sale+OE	11,000	$513.18	$5,644,953.77	-3.5%	+3.3%	-
Dec 11, 2025	UTHR United Therapeutics Corp	EVP &General Counsel	Sale+OE	11,000	$484.67	$5,331,315.56	-4.3%	+11.5%	-
Nov 26, 2025	UTHR United Therapeutics Corp	EVP &General Counsel	Sale+OE	11,000	$486.06	$5,346,701.20	-4.2%	-3.1%	-
Sep 18, 2025	UTHR United Therapeutics Corp	EVP &General Counsel	Sale+OE	11,000	$406.17	$4,467,908.11	-4.2%	+24.7%	-
Sep 4, 2025	UTHR United Therapeutics Corp	EVP &General Counsel	Sale+OE	11,000	$385.21	$4,237,281.09	-2.0%	+26.4%	-